Sentences with phrase «develops pharmaceutical products»

Concordia Healthcare Corp. develops pharmaceutical products and medical devices.

This led to the cessation of all U.S. sales indefinitely, even though according to the latest information on Rock Creek's website they are still manufacturing and developing pharmaceutical products.

Not exact matches

In Africa, for example, some smaller pharmaceutical companies have profitably sold generic drugs and commercially developed local products.

But the company is also developing products that use pharmaceutical cannabinoids, a synthetic version of marijuana.

Valeant Pharmaceuticals International, Inc. (NYSE / TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics.

We may face increasing competition for additional new product acquisitions from pharmaceutical companies as new companies emerge with a similar business model and other more established companies focus on acquiring products to develop their pipeline.

Shire is a Dublin - based biopharmaceutical company that researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products.

Developed with Cargolux to help minimize spoilage during transit, Tyvek ® Air Cargo Covers are ideal for shipping fruit, vegetable, floral, and pharmaceutical products, even under the roughest environmental conditions.

As industry experts in the manufacturing of cosmetics, food, pharmaceuticals and technical products, we have developed a spectrum of expertise that makes us your ultimate solution provider.

Dr. Smith, who assumed the role of Interim Chief Executive Officer in August 2016, brings over 20 years developing and managing product and business opportunities in the agricultural, human and animal nutrition, and pharmaceutical industries.

In a joint venture with the packaging manufacturer, Edelmann, Schreiner MediPharm has developed an innovative solution that makes important product information accessible without opening the pharmaceutical pack.

In medicine today, physician - scientists and basic scientists supplement support for their research by applying their expertise part time to develop and test commercial products.1 In my own field, vision science, university - based researchers obtain additional funding through clinical and electrophysiologic studies, pathology, imaging, biochemistry, and animal model development performed for pharmaceutical and instrument companies.

Meanwhile bigger, well - established pharmaceutical companies such as Novartis in France, Roche and Boehringer Ingelheim in Germany, and Akzo Nobel through its biotech branch Diosynth in the Netherlands — to name only a few — are also developing their own production facilities for biotech products.

High in the Cederberg Mountains of South Africa grows a bristly shrub that embodies the tug - of - war taking place between industrialized and developing nations over the value of genetic resources — the genes found in plant, animal or microbial cells used for research as well as in commercial products, such as enhanced seeds and naturally derived cosmetics and pharmaceuticals.

Large companies, always under pressure to reduce costs, have determined that pharmaceutical products can be developed and manufactured cheaply offshore.

The recent approval of SpinrazaTM (nusinersen), jointly developed by Ionis Pharmaceuticals and Biogen, marks the arrival of a new class of biological products — oligonucleotide therapeutics.

Now, Wyss Institute researchers led by Church have developed a new suite of such sensors, reported in Nucleic Acids Research journal, that not only increase the number of cellular «switches and levers» that scientists can use for complex genetic re-programming, but also respond to valuable products such as renewable plastics or costly pharmaceuticals and give microbes a voice to report on their own efficiency in making these products.

On 1 May 2002, CNPR incorporated to become MerLion Pharmaceuticals, a home - grown Singapore drug discovery company that aims to develop new drugs for human therapy from natural product leads.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

It is currently developing drugs in partnership with Bridgewater, N.J. - based Ortho Biotech Products LP (kidney disease), San Francisco - based Genentech Inc. (cancer) and Collegeville, Pa. - based Wyeth Pharmaceuticals (neurological disorders).

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Tom later left SIBIA to work at Telios Pharmaceuticals, where he developed peptide based products for wound healing.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Prior PLM Medical, a company that specialises in supporting the medical and pharmaceutical industry to develop drug delivery devices from initial idea to end of product life.

Simply put, CROs work with pharmaceutical and device companies to help them develop their drugs and medical devices and bring them to the market, as well as work with clients after their product has been approved on post-marketing approval studies, as well as commercialization.

We develop simulations for a wide range of trainings including software training, product & sales training, and pharmaceutical & healthcare training.

To develop and register new medicines, vaccines, diagnostic tests and pharmaceutical products after careful examination

It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in - license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas.

Many net - nets are in the process of developing highly technological products or pharmaceuticals, or they may be searching for rare minerals or fossil fuels.

Supernus Pharmaceuticals, Inc. develops and commercializes products for the treatment of central nervous system.

JNJ is actually a holding company in the business of manufacturing, developing, and selling personal care and healthcare products such as toiletries and over-the-counter pharmaceuticals.

Worse yet, there are no new products being developed by the pharmaceutical companies, so we need to make what we have last!

Even though recent studies have shown that fleas and ticks have not developed resistance to common preventatives, our pharmaceutical suppliers have produced several new or updated products to help protect our pets from these pests.

Elanco is a leading innovation - driven corporation committed to developing a growing portfolio of best - in - class and first - in - class pharmaceutical products to enable veterinarians to help pets live longer, healthier, higher quality lives.

Aratana Therapeutics focuses on licensing, developing and commercializing innovative pharmaceutical products for dogs and cats.

JOHNSON & JOHNSON Investing in the health of the planet Johnson & Johnson is a leading healthcare company that develops and markets pharmaceuticals, medical devices and consumer products worldwide.

Jeeva's client was an engineering technician who developed a severe skin condition from contact with chemical components during the manufacture of pharmaceutical products.

Without such legislation pharmaceutical companies would be quite reluctant to develop and market orphan products as the returns would rarely justify the necessary investments.

We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.

Resume format for dietician incorporates responsibilities of assessing, promoting, protecting and enhancing the overall health of others for preventing diseases borne of ill nutrition in addition to manage a cost effective food production operation, supervising sanitation and safety standards in a food service setting, to work with individuals, groups, workplaces and media for offering dietary advice for healthy living, to work with food and pharmaceutical companies for providing research, developing products, educating consumers and promoting better food and nutritional products in a business setting.

Sample resumes for this position showcase skills like creating and implementing formulations development strategies for solid dosage generic drugs, developing generic pharmaceutical formulations, managing the product development process, and coordinating with strategic heads for sourcing development, QA, manufacturing, and other teams involved in scheduling and planning.

Highlights Upsold from generic to brand name pharmaceuticals to 25 percent of customers each year Maintained relationships with primary care physicians, surgeons, specialists and hospitals that led to primary access for new and existing products Led a team of three sales representatives for the greater Chicago area that exceeded sales goal by at least 10 percent each quarter Provided excellent customer service that led to a 90 percent client retention rate, the highest in the company Knowledge of the latest industry trends, and proficient in the product catalogue Experience Medical Sales Representative and Supervisor 9/1/2013 — Current LIEO Pharmaceuticals — Chicago, IL Oversee three sales representatives, organizing and developing sales routes pharmaceuticals to 25 percent of customers each year Maintained relationships with primary care physicians, surgeons, specialists and hospitals that led to primary access for new and existing products Led a team of three sales representatives for the greater Chicago area that exceeded sales goal by at least 10 percent each quarter Provided excellent customer service that led to a 90 percent client retention rate, the highest in the company Knowledge of the latest industry trends, and proficient in the product catalogue Experience Medical Sales Representative and Supervisor 9/1/2013 — Current LIEO Pharmaceuticals — Chicago, IL Oversee three sales representatives, organizing and developing sales routes Pharmaceuticals — Chicago, IL Oversee three sales representatives, organizing and developing sales routes and techniques.

Highlights Expanded market share for various pharmaceuticals by at least 20 percent per year Developed strong relationships with primary care physicians and specialists to be allowed first access to promote new products Masterful understanding of a variety of pharmaceuticals and medical equipment Excellent verbal and written communication skills Created a territory business plan that resulted in an increase in sales that exceeded goals by 50 percent Solid knowledge of the cost issues practitioners face Educated in disease processes and pathology as well as the traditional care and treatment for various disorders Experience Medical Sales Representative 4/1/2012?

SUMMARY Dynamic Director / Program Leader with over 17 years managing large business transformation initiatives and developing Project Management Offices (PMOs) in pharmaceutical, technology, and consumer products industries.

At Medicis, I developed and maintained the procedure for reimbursement of employees for use of the company's pharmaceutical products, according to FDA rules and regulations.

* Successfully developed several prototypes and launched multiple FDA / CE regulated platforms, devices and Class I - II - III products and plastic consumables for medical, diagnostics, biotech and pharmaceutical applications from concept t...

Tags for this Online Resume: clinical, affairs, scientific, trials, innovative, management, summary, documents, submission, regulatory, 510 (k), ISE, ISS, PK / PD, communicating, monitoring, tactical, strategic, literature, direct, vision, Lead, Director, documentation, resources, execution, consensus, effectiveness, safety, CRA, IVD, medical, device, pharmaceutical, presentation, manuscript, abstract, poster, programs, leadership, career, development, appraisals, optimize, goals, objectives, internal, external, research, investigator, stakeholders, customers, prioritize, product, support, milestones, Microsoft, Word, Excel, statistics, data, analysis, Powerpoint, publication, growth, deliverables, diagnostic, prognostic, treatment, competitive, proven, ability, capable, assess, strategy, feasibility, methodology, design, develop, produce, recommend, recommendation, therapeutic, supervision, review, performance, appraisal, application, indication, company, collaborate, expert, justification, senior, executive, assessment, experienced, marketing, pre-market, pre-IDE, protocol, communication, utility, pharmacology, service, deliver, delivery, drug, metabolism, absorption, excretion, train, training, mentor, mentoring, CRO, reimbursement, XLSTAT, Prism, relationship, contract, consult, consultant, ownership, responsibility, authority, delegate, trends, direction, in - vitro, commercialize, commercialization, approval, clearance, patient, oncology, cancer, metabolic, cardiovascular, kidney, disease, health, outcomes, safe, effective, toxicity, novel, unique, unmet, need, advisors, advisory, committee, IRB, ethical, justified, supportive, care, associate

I was in charge of the team that developed three generations of the product before it was sold to Rodenstock in Germany when Alcon purchased Coopervision for the pharmaceutical and surgical divisions.

Pharmaceutical Sales Representative — Duties & Responsibilities Direct pharmaceutical sales, marketing, and customer service ensuring professional and profitable operations Consistently recognized as company leader in sales, customer service, and team development Set and strictly adhere to departmental budgets and project timelines Negotiate lucrative contracts with clients, vendors, and suppliers Generate record breaking sales through networking, in personal sales, and other tactics Make cold calls in a courteous, yet assertive manner that translates to sales results Build and strengthen relationships with key clients, partners, and industry leaders Maintain 100 % customer satisfaction by maintaining friendly, supportive contact with existing clients Study internal literature to become an expert on pharmaceutical products Conduct research on prospective leads and existing clients to assist in developing sales strategies Craft effective sales presentations and proposals, tailoring them to clients based on their specific needs and styles Maintain records of site visits to potential and existing clients to assist in assessing their future needs Collaborate with junior level sales people to develop action plans to govern their performance Train junior team members in sales and customer service best practices Maintain comprehensive records detailing pricings, sales, activities reports, and other pertinent data Represent company brand with poise, integrity, and positivity